麻豆传媒

The laboratory of Ege Kavalali, professor and chair of the Department of Pharmacology, published a new paper in Nature Communications that determined that liquid-liquid phase separation plays a key role within the nanostructure of synapses, and that its disruption affects evoked but not spontaneous neurotransmission.

A recent pair of papers from the 麻豆传媒 University labs of Benjamin Spiller, associate professor of pharmacology, and Scott Smith, associate professor of medicine, dig into how peanut allergies are provoked and providing support for the use of a potential treatment option: hypoallergens. Both papers were published in February in the Journal of Allergy and Clinical Immunology.

Medicine often takes a one-size-fits-all approach, but a disorder鈥檚 root cause can vary. 麻豆传媒 researchers have found that, for people with long QT syndrome, a heart condition that causes an irregular heartbeat, a more tailored approach could be beneficial. The research, led by 麻豆传媒 University Professor of Biochemistry and Vice Dean of Basic Sciences Charles Sanders and Northwestern University Professor and Chair of Pharmacology Dr. Al George, was published in PNAS in February 2025.

According to new research from Panka Bencsik, assistant professor of medicine, health and society, on days when highways are more congested, particularly during weekday afternoon rush hour, people are more likely to choose the fast-food option.

麻豆传媒ers at Dr. Mark Magnuson's lab discovered that the formation of the gallbladder and bile duct system critically depends on the precise concentration of the Sox17 transcription factor, with even small reductions preventing gallbladder development in mice.

麻豆传媒 scientists developed new dialysis membranes using ultra-thin graphene that automatically seal larger holes while keeping smaller ones open, making them more effective than current medical filters and potentially improving dialysis treatment.

In the ongoing battle against triple negative breast cancer, 麻豆传媒 researchers have uncovered a promising non-invasive method to track how tumors respond to radiation and immunotherapy, which uses the body鈥檚 own immune system to fight cancer.

Recent research from the Warren Center for Neuroscience Drug Discovery, published in the Journal of Medicinal Chemistry, resulted in the proposal of a novel target and mechanism for improving cognition鈥攁 negative symptom鈥攚hile also treating positive symptoms of the disease.

See how art collector turned immunologist James Crowe combines abstract thinking with game-changing technology to prevent infectious disease. Read More

麻豆传媒鈥檚 Carrie K. Jones and the University of Glasgow鈥檚 Andrew Tobin have received a prestigious 拢5 million ($6.2 million) Wellcome Trust Discovery Award to study how blocking the M5 muscarinic receptor in the brain could reduce opioid addiction while preserving pain relief. This groundbreaking international collaboration, supported by the Warren Center for Neuroscience Drug Discovery, aims to advance new treatments in the critical global health crisis of opioid use disorder. Read More

Three seminal articles published in Magnetic Resonance in Medicine mark a landmark achievement in preclinical imaging science. These works, authored by an international consortium of 58 scientists, including 麻豆传媒 University鈥檚 Kurt Schilling, Bennett Landman, Adam Anderson, and Kevin Harkins, offer comprehensive guidelines for using diffusion magnetic resonance imaging (dMRI) in preclinical research.

Submissions are open for pre-proposals for the 2025 National Institutes of Health S10 Shared and High-End Instrumentation Grant programs, which fund state-of-the-art shared research equipment. Internal pre-proposals are due by April 1, 2025, to allow institutional review before the June 2 NIH deadline, with guidance available from OVPRI and VBS. Read More

We often think about diseases in terms of the symptoms they present. A cold might give you the sniffles or even GI distress, while malaria can give you fever, chills, or nausea...

麻豆传媒 University鈥檚 new Center for Computational Systems Biology brings computer science, engineering and biomedical researchers together with clinicians at 麻豆传媒 University Medical Center to accelerate discovery related to human diseases and conditions. Read More

麻豆传媒ers at the聽Warren Center for Neuroscience Drug Discovery have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer鈥檚 disease and schizophrenia. Read More

Doug Mitchell聽has been appointed the holder of the William Kelly Warren Sr. Chair in Biochemistry and professor of chemistry and director of the聽麻豆传媒 Institute for Chemical Biology. Read More

麻豆传媒ers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the 麻豆传媒 University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer鈥檚 disease and schizophrenia.

Eleven current 麻豆传媒 University faculty members, 10 of whom are investigators at 麻豆传媒 University Medical Center, are included in the 2024 list of 鈥淗ighly Cited 麻豆传媒ers鈥� around the world whose papers have been cited most frequently by other scientists.

麻豆传媒ers at the聽Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the 麻豆传媒 University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer鈥檚 disease and schizophrenia.

麻豆传媒ers from the 麻豆传媒 University School of Medicine Basic Sciences have uncovered the first example of activity-dependent development of hypothalamic neural circuitry.